Literature DB >> 23948639

Loss of MeCP2 function is associated with distinct gene expression changes in the striatum.

Ying-Tao Zhao1, Darren Goffin, Brian S Johnson, Zhaolan Zhou.   

Abstract

Rett syndrome (RTT) is a neurodevelopmental disorder characterized by developmental regression beginning 6-18months after birth, followed by a lifetime of intellectual disability, stereotyped behaviors, and motor deficits. RTT is caused by mutations in the gene encoding MeCP2, a methyl-CpG binding protein believed to modulate gene transcription. Gene expression studies of individual brain regions have reported that Mecp2 loss-of-function leads to both activation and repression of its gene targets in mice. Conditional deletion of MeCP2 from different brain regions has revealed unique insights into the role of these structures in mediating particular RTT-like phenotypes. However, the function of MeCP2 in the striatum, a major brain region involved in motor control and executive cognitive functions, has yet to be studied. Here, we characterized the gene expression changes in the striatum of Mecp2 mutant mice. We found a number of differentially expressed genes in the striatum of both constitutive Mecp2-null mice and mice lacking MeCP2 only from forebrain GABAergic neurons. These changes only occurred when MeCP2 expression levels had reached mature levels and RTT-like symptoms were manifest, supporting a role for MeCP2 in maintaining proper brain function. Many of the gene expression changes identified in the striatum have not previously been shown to change in the hypothalamus or cerebellum. Bioinformatic analysis of differentially expressed genes in striatum as well as hypothalamus and cerebellum revealed that loss of MeCP2 does not affect the global landscape of gene expression. Additionally, we uncovered a number of differentially expressed genes in the liver of Mecp2-null mice suggesting an important role for MeCP2 in non-neuronal tissues. Collectively, our data suggest that the differential expression of genes following loss of MeCP2 occurs in a tissue- or cell-type specific manner and thus MeCP2 function should be understood in a cellular context.
© 2013.

Entities:  

Keywords:  Gene expression; MeCP2; Methyl-CpG binding protein 2; RTT; Rett syndrome; Striatum; WGCNA; methyl-CpG binding protein 2; weighted gene co-expression network analysis

Mesh:

Substances:

Year:  2013        PMID: 23948639      PMCID: PMC3790640          DOI: 10.1016/j.nbd.2013.08.001

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  40 in total

1.  Neuroanatomy in Rett syndrome: cerebral cortex and posterior fossa.

Authors:  B Subramaniam; S Naidu; A L Reiss
Journal:  Neurology       Date:  1997-02       Impact factor: 9.910

2.  A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.

Authors:  J Guy; B Hendrich; M Holmes; J E Martin; A Bird
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

3.  Postnatal inactivation reveals enhanced requirement for MeCP2 at distinct age windows.

Authors:  Hélène Cheval; Jacky Guy; Cara Merusi; Dina De Sousa; Jim Selfridge; Adrian Bird
Journal:  Hum Mol Genet       Date:  2012-05-31       Impact factor: 6.150

4.  Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities.

Authors:  Rodney C Samaco; Caleigh Mandel-Brehm; Hsiao-Tuan Chao; Christopher S Ward; Sharyl L Fyffe-Maricich; Jun Ren; Keith Hyland; Christina Thaller; Stephen M Maricich; Peter Humphreys; John J Greer; Alan Percy; Daniel G Glaze; Huda Y Zoghbi; Jeffrey L Neul
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-09       Impact factor: 11.205

5.  Adult neural function requires MeCP2.

Authors:  Christopher M McGraw; Rodney C Samaco; Huda Y Zoghbi
Journal:  Science       Date:  2011-06-02       Impact factor: 47.728

6.  Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes.

Authors:  Hsiao-Tuan Chao; Hongmei Chen; Rodney C Samaco; Mingshan Xue; Maria Chahrour; Jong Yoo; Jeffrey L Neul; Shiaoching Gong; Hui-Chen Lu; Nathaniel Heintz; Marc Ekker; John L R Rubenstein; Jeffrey L Noebels; Christian Rosenmund; Huda Y Zoghbi
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

7.  Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responses.

Authors:  Darren Goffin; Megan Allen; Le Zhang; Maria Amorim; I-Ting Judy Wang; Arith-Ruth S Reyes; Amy Mercado-Berton; Caroline Ong; Sonia Cohen; Linda Hu; Julie A Blendy; Gregory C Carlson; Steve J Siegel; Michael E Greenberg; Zhaolan Zhou
Journal:  Nat Neurosci       Date:  2011-11-27       Impact factor: 24.884

8.  Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress.

Authors:  Sharyl L Fyffe; Jeff L Neul; Rodney C Samaco; Hsiao-Tuan Chao; Shay Ben-Shachar; Paolo Moretti; Bryan E McGill; Evan H Goulding; Elinor Sullivan; Laurence H Tecott; Huda Y Zoghbi
Journal:  Neuron       Date:  2008-09-25       Impact factor: 17.173

Review 9.  Preclinical research in Rett syndrome: setting the foundation for translational success.

Authors:  David M Katz; Joanne E Berger-Sweeney; James H Eubanks; Monica J Justice; Jeffrey L Neul; Lucas Pozzo-Miller; Mary E Blue; Diana Christian; Jacqueline N Crawley; Maurizio Giustetto; Jacky Guy; C James Howell; Miriam Kron; Sacha B Nelson; Rodney C Samaco; Laura R Schaevitz; Coryse St Hillaire-Clarke; Juan L Young; Huda Y Zoghbi; Laura A Mamounas
Journal:  Dis Model Mech       Date:  2012-11       Impact factor: 5.758

10.  Mecp2-null mice provide new neuronal targets for Rett syndrome.

Authors:  Rocio G Urdinguio; Lidia Lopez-Serra; Pilar Lopez-Nieva; Miguel Alaminos; Ramon Diaz-Uriarte; Agustin F Fernandez; Manel Esteller
Journal:  PLoS One       Date:  2008-11-07       Impact factor: 3.240

View more
  24 in total

Review 1.  Diverse and dynamic DNA modifications in brain and diseases.

Authors:  Matthew J Armstrong; Yulin Jin; Emily G Allen; Peng Jin
Journal:  Hum Mol Genet       Date:  2019-11-21       Impact factor: 6.150

Review 2.  Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits.

Authors:  Samuel S Pappas; Daniel K Leventhal; Roger L Albin; William T Dauer
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

3.  Targeted Interneuron Depletion in the Dorsal Striatum Produces Autism-like Behavioral Abnormalities in Male but Not Female Mice.

Authors:  Maximiliano Rapanelli; Luciana Romina Frick; Meiyu Xu; Stephanie Mary Groman; Kantiya Jindachomthong; Nobuaki Tamamaki; Chiyoko Tanahira; Jane Rebecca Taylor; Christopher Pittenger
Journal:  Biol Psychiatry       Date:  2017-02-10       Impact factor: 13.382

4.  MECP2 impairs neuronal structure by regulating KIBRA.

Authors:  Alison A Williams; Robin White; Ashley Siniard; Jason Corneveaux; Matt Huentelman; Carsten Duch
Journal:  Neurobiol Dis       Date:  2016-03-22       Impact factor: 5.996

5.  Functional Genomic Analyses Identify Pathways Dysregulated in Animal Model of Autism.

Authors:  Ji-Yun Huang; Yun Tian; Hui-Juan Wang; Hong Shen; Huan Wang; Sen Long; Mei-Hua Liao; Zhi-Rong Liu; Ze-Ming Wang; Dan Li; Rong-Rong Tao; Tian-Tian Cui; Shigeki Moriguchi; Kohji Fukunaga; Feng Han; Ying-Mei Lu
Journal:  CNS Neurosci Ther       Date:  2016-06-20       Impact factor: 5.243

6.  Total RNA Sequencing of Rett Syndrome Autopsy Samples Identifies the M4 Muscarinic Receptor as a Novel Therapeutic Target.

Authors:  Rocco G Gogliotti; Nicole M Fisher; Branden J Stansley; Carrie K Jones; Craig W Lindsley; P Jeffrey Conn; Colleen M Niswender
Journal:  J Pharmacol Exp Ther       Date:  2018-03-09       Impact factor: 4.030

Review 7.  Genomic insights into MeCP2 function: A role for the maintenance of chromatin architecture.

Authors:  Daniel R Connolly; Zhaolan Zhou
Journal:  Curr Opin Neurobiol       Date:  2019-08-17       Impact factor: 6.627

8.  Elevating expression of MeCP2 T158M rescues DNA binding and Rett syndrome-like phenotypes.

Authors:  Janine M Lamonica; Deborah Y Kwon; Darren Goffin; Polina Fenik; Brian S Johnson; Yue Cui; Hengyi Guo; Sigrid Veasey; Zhaolan Zhou
Journal:  J Clin Invest       Date:  2017-04-10       Impact factor: 14.808

9.  DNA methylation in the gene body influences MeCP2-mediated gene repression.

Authors:  Benyam Kinde; Dennis Y Wu; Michael E Greenberg; Harrison W Gabel
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-13       Impact factor: 11.205

10.  Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.

Authors:  Harrison W Gabel; Benyam Kinde; Hume Stroud; Caitlin S Gilbert; David A Harmin; Nathaniel R Kastan; Martin Hemberg; Daniel H Ebert; Michael E Greenberg
Journal:  Nature       Date:  2015-03-11       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.